194 related articles for article (PubMed ID: 5545123)
1. Complement-derived leukotactic factors in inflammatory synovial fluids of humans.
Ward PA; Zvaifler NJ
J Clin Invest; 1971 Mar; 50(3):606-16. PubMed ID: 5545123
[TBL] [Abstract][Full Text] [Related]
2. Activation of complement components C3 and factor B in synovial fluids.
Hunder GG; McDuffie FC; Mullen BJ
J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
Desai U; Dickey B; Varani J; Kreutzer DL
J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
[TBL] [Abstract][Full Text] [Related]
4. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
[TBL] [Abstract][Full Text] [Related]
5. Breakdown products of C 3 in human synovial fluids.
Zvaifler NJ
J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
[TBL] [Abstract][Full Text] [Related]
6. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
[TBL] [Abstract][Full Text] [Related]
7. Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.
Venge P; Olsson I
J Immunol; 1975 Dec; 115(6):1505-8. PubMed ID: 1184964
[TBL] [Abstract][Full Text] [Related]
8. Complement-derived leukotactic factors in pathological fluids.
Ward PA
J Exp Med; 1971 Sep; 134(3 Pt 2):109s-113s. PubMed ID: 5570748
[No Abstract] [Full Text] [Related]
9. [Studies on the mechanism of decrease in complement levels in the synovial fluid during rheumatoid arthritis. 3. Comparison between the quantitative consumption of total complement and its first 2 components (C1 and C2) during antigen-antibody reactions].
Leroy CJ; Peltier AP
Pathol Biol (Paris); 1972 Dec; 20(23):993-9. PubMed ID: 4568038
[No Abstract] [Full Text] [Related]
10. Complement-derived leukotactic factors in pathological fluids.
Ward PA
J Exp Med; 1971 Sep; 134(3):109-13. PubMed ID: 19867360
[TBL] [Abstract][Full Text] [Related]
11. Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.
Hedberg H; Lundh B; Laurell AB
Clin Exp Immunol; 1970 May; 6(5):707-12. PubMed ID: 5477926
[TBL] [Abstract][Full Text] [Related]
12. Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor.
Lett-Brown MA; Boetcher DA; Leonard EJ
J Immunol; 1976 Jul; 117(1):246-52. PubMed ID: 932427
[TBL] [Abstract][Full Text] [Related]
13. Leukotactic factors in health and disease.
Ward PA
Am J Pathol; 1971 Sep; 64(3):521-30. PubMed ID: 5133515
[TBL] [Abstract][Full Text] [Related]
14. Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.
Orr FW; Delikatny EJ; Mokashi S; Krepart GV; Stiver HG
Am J Pathol; 1983 Jan; 110(1):41-7. PubMed ID: 6185003
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.
Orr W; Varani J; Ward PA
Am J Pathol; 1978 Nov; 93(2):405-22. PubMed ID: 568888
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteins.
Lu-Steffes M; Iammartino AJ; Schmid FR; Castor CW; Davis L; Entwistle R; Anderson B
Ann Clin Lab Sci; 1982; 12(3):178-85. PubMed ID: 7092168
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactants in rheumatoid synovial effusions.
Zvaifler NJ
J Exp Med; 1971 Sep; 134(3):276-85. PubMed ID: 19867372
[TBL] [Abstract][Full Text] [Related]
18. Studies on the first component of complement (C1) and the inhibitor of C1 esterase in rheumatoid synovial fluids.
De Bracco MM; Stroud RM; Christian CL
Clin Exp Immunol; 1972 Jun; 11(2):209-18. PubMed ID: 4625157
[TBL] [Abstract][Full Text] [Related]
19. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
[TBL] [Abstract][Full Text] [Related]
20. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
